Glycosyl derivatives of NK2 tachykinin receptor antagonists
The syntheses and the activity on RPA and HT of some glycopeptides of NK2 tachykinin receptor antagonists are reported.
References (21)
- et al.
BioMed. Chem.
(1994) - et al.
J. Pharm. Sci.
(1990) - et al.
Life Sci.
(1992) - et al.
Carbohydrate Res.
(1992) - et al.
Eur. J. Pharmacol.
(1990) - et al.
Peptides
(1992) - et al.
- et al.
- et al.
J. Med. Chem.
(1991) - et al.
J. Auton. Pharmacol.
(1993)
There are more references available in the full text version of this article.
Cited by (8)
Synthesis of MEN11420, a glycosylated bicyclic peptide, by intramolecular double cyclization using a chloroimidazolinium coupling reagent
2001, TetrahedronCitation Excerpt :excess of Fmoc-Dap(Boc)-OH, Fmoc-Phe-OH, Fmoc-Trp-OH and Fmoc-Asp(OBut)-OH were conducted by a combination of piperidine-mediated deprotection and DIPCDI-mediated coupling. The N-terminal glycosylated residue, Fmoc-Asn(Ac3AcNH-β-Glc)-OH,14 was introduced by the same procedure, except that a 1.3 equiv. excess of the glycosylated amino acid and an extended coupling reaction (6 h) were employed.
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases
1999, Bioorganic and Medicinal Chemistry LettersThe neurokinins: Peptidomimetic ligand design and therapeutic applications
2020, Current Medicinal ChemistryCarbohydrates in Peptide and Protein Design
2009, Peptide and Protein Design for Biopharmaceutical ApplicationsTachykinin receptors antagonists: From research to clinic
2006, Current Drug TargetsCarbohydrates in peptide and protein design
2005, Biopolymers - Peptide Science Section
Copyright © 1996 Published by Elsevier Ltd.